1-Chloro-2,4-difluoro-3-nitrobenzene, 95.0%, 1g

(4S,5R)-3-(tert-Butoxycarbonyl)-2,2-dimethyl-4-phenyloxazolidine-5-carboxylic acid, 95.0%, 25g

5-Bromo-2-nitroisonicotinic acid, 95.0%, 5g

4-Bromo-3-methylaniline>98.0%(GC)25g

Ethyl 2-(4-Bromophenyl)-4-methylthiazole-5-carboxylate, 5g

(S)-3-((tert-Butoxycarbonyl)amino)-2-hydroxypropanoic acid, 95.0%, 10g

1-Methoxy-4-nitronaphthalene, 98.0%, 25g

1-Bromo-3-benzyloxy-4,5-difluorobenzene, 97.0%, 5g

3-Furanmethanol, 95.0%, 100g

Methyl 6-(1H-pyrazol-1-yl)nicotinate, 95.0%, 1g

2-CHLORO-5-NITROISONICOTINALDEHYDE, 95.0%, 250mg

1,6-Hexanediaminium, N1,N6-bis[3-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)propyl]-N1,N1,N6,N6-tetramethyl-, bromide (1:2), 98%, 5mg

GC capillary column ROTI®Cap-FFAP, 10 m, 0.10 mm, 0.10 µm, 1 Piece(s)